MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2026.1795481

Медицинская библиотека · Frontiers in immunology · 2026

Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer.

Lu Xinglong, Cui Xiang, Chen Hao, Zhang Jianling, Zhao Shengbing, Yang Baoshun, Yang Yang, Du Nan, Ma Wenxiang, An Jixi, Yu Yongjiang

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The predictive value of hematological parameters for pathologic response to neoadjuvant immunochemotherapy (NICT) in locally advanced gastric cancer (LAGC) remains unclear.

METHODS

This retrospective study consecutively enrolled 246 LAGC patients who received NICT followed by radical gastrectomy at The First Hospital of Lanzhou University (2021-2024). Based on postoperative pathology, patients were classified into major pathologic response (MPR, tumor regression grade [TRG] 1a/1b, residual tumor ≤10%) and incomplete pathologic response (IPR, TRG 2/3, residual tumor >10%) groups. Hematological parameters pre- and post-treatment were analyzed. Logistic regression and receiver operating characteristic (ROC) analyses were employed (statistical significance: p<0.05).

RESULTS

Multivariate analysis identified pre-treatment neutrophil count (Neutrophil_pre) (adjusted odds ratio [OR]: 0.83, 95% CI: 0.70-0.99, P = 0.033) and post-treatment albumin (ALB_post) (adjusted OR: 0.92, 95% CI: 0.85-1.00, P = 0.042) as independent protective factors for MPR, while post-treatment platelet count (PLT_post) was an independent risk factor (adjusted OR: 1.01, 95% CI: 1.00-1.01, P = 0.014). These associations were absent in a chemotherapy-alone control cohort (n=147). ROC analysis determined the optimal pre-treatment neutrophil cutoff at 3.39×109/L. Subgroup analysis showed that among patients with pre-treatment neutrophils <3.39×109/L, those receiving 4 (vs. 2-3) cycles of neoadjuvant therapy had significantly higher MPR (35.7% vs. 16.9%, P = 0.039) and pathologic complete response (pCR) rates (32.1% vs. 9.1%, P = 0.011).

CONCLUSION

Pre-treatment neutrophil count, post-treatment platelet count, and post-treatment albumin level are independent predictors of pathologic response to NICT in LAGC. Patients with low pre-treatment neutrophil levels may benefit from extended (4-cycle) neoadjuvant immunochemotherapy with higher pathologic response rates.

Для цитирования: Lu Xinglong, Cui Xiang, Chen Hao, Zhang Jianling, Zhao Shengbing, Yang Baoshun, Yang Yang, Du Nan, Ma Wenxiang, An Jixi, Yu Yongjiang. Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer.. Frontiers in immunology. 2026. DOI: 10.3389/fimmu.2026.1795481.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.